Press release
Global Hydroxychloroquine Market Gains Momentum Amid Rising Malaria Cases and Increased R&D in Pharmaceutical Sector
The global hydroxychloroquine market size was USD 997.3 Million in 2022 and is expected to register a rapid revenue CAGR of 5.6% during the forecast period. The global hydroxychloroquine market is experiencing significant growth due to an increase in malaria cases, particularly in emerging economies, and heightened research and development efforts by major pharmaceutical companies aimed at creating more effective treatments. Hydroxychloroquine, an established anti-malarial drug, is widely used not only for treating acute malaria attacks but also as a treatment for autoimmune conditions such as rheumatoid arthritis and lupus erythematosus.
Key Drivers Fueling Market Expansion
Hydroxychloroquine's broad applications are essential in supporting its growth. It is recognized not only for treating acute malaria attacks but also for managing conditions like systemic lupus erythematosus (SLE) and rheumatoid arthritis. In 2022, malaria alone impacted approximately 249 million people globally, with 608,000 fatalities reported across 85 countries. The Asia Pacific region faced a particularly high malaria burden, accounting for 94% of all malaria cases worldwide and 95% of deaths, underscoring the urgent demand for effective treatments like hydroxychloroquine.
In addition to its anti-malarial use, hydroxychloroquine's potential was explored during the COVID-19 pandemic. In March 2020, Novartis International AG delivered 30 million doses to the U.S. Department of Health and Human Services for clinical trials aimed at evaluating its effectiveness against COVID-19. Beyond infectious diseases, hydroxychloroquine has shown promising results in reducing disease flares and controlling symptoms in lupus patients, such as joint pain and fatigue. Additionally, studies presented at ACR Convergence 2023 indicate that individuals with rheumatoid arthritis who use hydroxychloroquine have a reduced risk of developing nonalcoholic fatty liver disease.
Request a Sample Report with Table of Contents and Figures to click Here: @https://www.emergenresearch.com/request-sample/2815
Market Restraints and Challenges
Despite its wide applications, the hydroxychloroquine market faces challenges, particularly concerning safety and regulatory requirements. Cardiac side effects have been reported, especially when hydroxychloroquine is combined with other medications like azithromycin. The European Drugs Agency noted that high doses of hydroxychloroquine combined with other drugs could cause severe, and occasionally fatal, heart rhythm irregularities, posing a barrier to its global usage.
Segment Highlights
Distribution Channel Insights: Among distribution channels, online platforms led the market share in 2022. The rise of e-commerce in pharmaceuticals has made it easier for consumers to access essential medicines, even in areas with limited medical assistance. The convenience of home delivery and the wide availability of drugs on online platforms contribute to this segment's growth.
Disease-Specific Insights: Hydroxychloroquine is mainly used to combat malaria, rheumatoid arthritis, lupus, and, more recently, COVID-19. The malaria segment is expected to grow steadily, supported by rising malaria cases worldwide and hydroxychloroquine's established efficacy. Following malaria, rheumatoid arthritis is also a key segment, with a notable prevalence among late adolescents and older adults.
End-Use Dynamics: The hospitals and clinics segment continues to be the leading end-user in the hydroxychloroquine market. These facilities are preferred due to their specialized expertise, advanced equipment, and comprehensive care services, offering patients access to emergency services and a wide range of specialty treatments. Hospitals' adherence to strict safety protocols and collaborative medical practices makes them the primary choice for patients seeking high-quality care.
For More Details On this Report Click Here @https://www.emergenresearch.com/industry-report/hydroxychloroquine-market
Hydroxychloroquine Top Companies and Competitive Landscape
The global hydroxychloroquine market is fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective hydroxychloroquine solutions.
Torrent Pharmaceuticals Ltd.
Taj Pharmaceuticals Ltd.
Pfizer Inc.
Novartis AG
Hikma Pharmaceuticals PLC
Cadila Healthcare Ltd.
Genentech, USA Inc.
Zydus Cadila
Lupin
AJANTA PHARMA
Hydroxychloroquine Latest Industry News
In April 2023, Ipca Laboratories Ltd., which is an Indian pharmaceutical company, announced its acquisition of a 33.38% stake in Unichem Laboratories Ltd. for a sum of up to INR 10.34 billion (around 0.12 USD Billion). Ipca is initiating an open offer to purchase an extra 26% stake from Unichem's shareholders for 8.05 billion rupees, as stated in a regulatory filing.
In February 2022, Accord Healthcare Inc. introduced the additional strengths of hydroxychloroquine sulfate tablets in the United States. The generic version of Plaquenil, hydroxychloroquine, is typically used to treat malaria, lupus, and rheumatoid arthritis.
To Customized Report Market: @https://www.emergenresearch.com/request-for-customization/2815
Hydroxychloroquine Market Segment Analysis
For the purpose of this report, Emergen Research has segmented the global hydroxychloroquine market on the basis of product, distribution channel, diseases, end-use, and region:
Product Outlook (Revenue, USD Million; 2019-2032)
Tablet
Active Pharmaceutical Ingredients (APIs)
Distribution Channel Outlook (Revenue, USD Million; 2019-2032)
Hospital
Retail
Online
Specialty drug store
Diseases Outlook (Revenue, USD Million; 2019-2032)
Malaria
Rheumatoid arthritis
Lupus erythematosus
Coronavirus
Others
End-Use Outlook (Revenue, USD Million; 2019-2032)
Hospitals & clinics
Homecare
Others
Regional Outlook (Revenue, USD Million; 2019-2032)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Benelux
Russia
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
ASEAN Countries
Oceania
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
Israel
Turkey
South Africa
Rest of Middle East & Africa
Click Here To Buy Now @https://www.emergenresearch.com/select-license/2815
Unlocking Opportunities: Detailed Market Assessment and Strategy
Hydroxychloroquine Market Size @ https://www.emergenresearch.com/industry-report/hydroxychloroquine-market/market-size
Hydroxychloroquine Market Share @ https://www.emergenresearch.com/industry-report/hydroxychloroquine-market/market-share
Hydroxychloroquine Market Trends @ https://www.emergenresearch.com/industry-report/hydroxychloroquine-market/market-trends
Hydroxychloroquine Regional Market Demand @ https://www.emergenresearch.com/industry-report/hydroxychloroquine-market/regional-market-demand
Hydroxychloroquine Market Analysis @ https://www.emergenresearch.com/industry-report/hydroxychloroquine-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Key Drivers Fueling Market Expansion
Hydroxychloroquine's broad applications are essential in supporting its growth. It is recognized not only for treating acute malaria attacks but also for managing conditions like systemic lupus erythematosus (SLE) and rheumatoid arthritis. In 2022, malaria alone impacted approximately 249 million people globally, with 608,000 fatalities reported across 85 countries. The Asia Pacific region faced a particularly high malaria burden, accounting for 94% of all malaria cases worldwide and 95% of deaths, underscoring the urgent demand for effective treatments like hydroxychloroquine.
In addition to its anti-malarial use, hydroxychloroquine's potential was explored during the COVID-19 pandemic. In March 2020, Novartis International AG delivered 30 million doses to the U.S. Department of Health and Human Services for clinical trials aimed at evaluating its effectiveness against COVID-19. Beyond infectious diseases, hydroxychloroquine has shown promising results in reducing disease flares and controlling symptoms in lupus patients, such as joint pain and fatigue. Additionally, studies presented at ACR Convergence 2023 indicate that individuals with rheumatoid arthritis who use hydroxychloroquine have a reduced risk of developing nonalcoholic fatty liver disease.
Request a Sample Report with Table of Contents and Figures to click Here: @https://www.emergenresearch.com/request-sample/2815
Market Restraints and Challenges
Despite its wide applications, the hydroxychloroquine market faces challenges, particularly concerning safety and regulatory requirements. Cardiac side effects have been reported, especially when hydroxychloroquine is combined with other medications like azithromycin. The European Drugs Agency noted that high doses of hydroxychloroquine combined with other drugs could cause severe, and occasionally fatal, heart rhythm irregularities, posing a barrier to its global usage.
Segment Highlights
Distribution Channel Insights: Among distribution channels, online platforms led the market share in 2022. The rise of e-commerce in pharmaceuticals has made it easier for consumers to access essential medicines, even in areas with limited medical assistance. The convenience of home delivery and the wide availability of drugs on online platforms contribute to this segment's growth.
Disease-Specific Insights: Hydroxychloroquine is mainly used to combat malaria, rheumatoid arthritis, lupus, and, more recently, COVID-19. The malaria segment is expected to grow steadily, supported by rising malaria cases worldwide and hydroxychloroquine's established efficacy. Following malaria, rheumatoid arthritis is also a key segment, with a notable prevalence among late adolescents and older adults.
End-Use Dynamics: The hospitals and clinics segment continues to be the leading end-user in the hydroxychloroquine market. These facilities are preferred due to their specialized expertise, advanced equipment, and comprehensive care services, offering patients access to emergency services and a wide range of specialty treatments. Hospitals' adherence to strict safety protocols and collaborative medical practices makes them the primary choice for patients seeking high-quality care.
For More Details On this Report Click Here @https://www.emergenresearch.com/industry-report/hydroxychloroquine-market
Hydroxychloroquine Top Companies and Competitive Landscape
The global hydroxychloroquine market is fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective hydroxychloroquine solutions.
Torrent Pharmaceuticals Ltd.
Taj Pharmaceuticals Ltd.
Pfizer Inc.
Novartis AG
Hikma Pharmaceuticals PLC
Cadila Healthcare Ltd.
Genentech, USA Inc.
Zydus Cadila
Lupin
AJANTA PHARMA
Hydroxychloroquine Latest Industry News
In April 2023, Ipca Laboratories Ltd., which is an Indian pharmaceutical company, announced its acquisition of a 33.38% stake in Unichem Laboratories Ltd. for a sum of up to INR 10.34 billion (around 0.12 USD Billion). Ipca is initiating an open offer to purchase an extra 26% stake from Unichem's shareholders for 8.05 billion rupees, as stated in a regulatory filing.
In February 2022, Accord Healthcare Inc. introduced the additional strengths of hydroxychloroquine sulfate tablets in the United States. The generic version of Plaquenil, hydroxychloroquine, is typically used to treat malaria, lupus, and rheumatoid arthritis.
To Customized Report Market: @https://www.emergenresearch.com/request-for-customization/2815
Hydroxychloroquine Market Segment Analysis
For the purpose of this report, Emergen Research has segmented the global hydroxychloroquine market on the basis of product, distribution channel, diseases, end-use, and region:
Product Outlook (Revenue, USD Million; 2019-2032)
Tablet
Active Pharmaceutical Ingredients (APIs)
Distribution Channel Outlook (Revenue, USD Million; 2019-2032)
Hospital
Retail
Online
Specialty drug store
Diseases Outlook (Revenue, USD Million; 2019-2032)
Malaria
Rheumatoid arthritis
Lupus erythematosus
Coronavirus
Others
End-Use Outlook (Revenue, USD Million; 2019-2032)
Hospitals & clinics
Homecare
Others
Regional Outlook (Revenue, USD Million; 2019-2032)
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Benelux
Russia
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
ASEAN Countries
Oceania
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East & Africa
GCC Countries
Israel
Turkey
South Africa
Rest of Middle East & Africa
Click Here To Buy Now @https://www.emergenresearch.com/select-license/2815
Unlocking Opportunities: Detailed Market Assessment and Strategy
Hydroxychloroquine Market Size @ https://www.emergenresearch.com/industry-report/hydroxychloroquine-market/market-size
Hydroxychloroquine Market Share @ https://www.emergenresearch.com/industry-report/hydroxychloroquine-market/market-share
Hydroxychloroquine Market Trends @ https://www.emergenresearch.com/industry-report/hydroxychloroquine-market/market-trends
Hydroxychloroquine Regional Market Demand @ https://www.emergenresearch.com/industry-report/hydroxychloroquine-market/regional-market-demand
Hydroxychloroquine Market Analysis @ https://www.emergenresearch.com/industry-report/hydroxychloroquine-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
